18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.

Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD
Ann Surg. 1999 229 (5): 729-37; discussion 737-8

PMID: 10235532 · PMCID: PMC1420818 · DOI:10.1097/00000658-199905000-00016

MeSH Terms (9)

Adenocarcinoma Fluorodeoxyglucose F18 Humans Pancreatic Neoplasms Predictive Value of Tests Radiopharmaceuticals Reproducibility of Results Sensitivity and Specificity Tomography, Emission-Computed

Connections (1)

This publication is referenced by other Labnodes entities: